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A.D. Giannoukas,1* N. Labropoulos2 and J.A. Michaels3Divisions of Vascular Surgery, 1University Hospital of Larissa, University of Thessaly Medical School, Larissa,
Greece; 2Loyola University Medical Center, Maywood, IL, USA; and 3Academic Vascular Unit, Northern
General Hospital, University of Sheffield, Sheffield, UKIntroduction. The aim of this study was to assess whether there is enough evidence to suggest that compression with or
without early ambulation after proximal DVT reduces the risk of post-thrombotic syndrome (PTS).
Methods. Systematic review based on electronic and hand searching of the relevant literature.
Results. Four randomized studies were identified and despite the fact that there was lack of uniformity in reporting
standards all but one showed significant risk reduction of PTS using compression. No difference in recurrent
thromboembolic events (DVT or pulmonary embolism) was observed between the compression and control group. In one
study the early outcome from the combination of early ambulation with compression was faster reduction of swelling with
better well-being without increased risk of PE compared to the control group. Pooled analysis of all studies showed that PTS
developed in 24% (61/254) in the compression group and in 46% (110/239) in the control group (c2Z25.36, pZ0.0001;
OR: 0.37, 95%CI: 0.25, 0.54; RR: 0.52, 95%CI: 0.40, 0.67; and RRR: 0.48, 95%CI: 0.33, 0.60) with a 48% risk reduction
from the use of compression.
Conclusion. Despite the fact that compression with or without early ambulation appears to be safe and it is more often
associated with a decreased rate of PTS, the four existing studies do not permit meaningful data comparison due to lack of
uniformity in reporting standards.Keywords: Post-thrombotic syndrome; Deep venous thrombosis; Compression; Early ambulation.Introduction
Over the last decade the treatment of deep venous
thrombosis (DVT) by the subcutaneous administration
of low molecular weight heparins has been proven to
be at least as effective and safe as conventional
unfractionated heparin.1–7
Although there is lack of consensus on the
definition of post-thrombotic syndrome (PTS), several
scoring systems have been designed to aid the
diagnosis.8–10 Previous history of DVT, aching, heavi-
ness, pruritus, oedema, skin thickening and hyperpig-
mentation, white skin atrophy, and ulceration are most
of the characteristic symptoms and signs of thising author. Athanasios D. Giannoukas, MSc, MD, PhD,
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hypertension because of outflow obstruction, vein
valve incompetence or both, whereas the calf muscle
pump plays an important role in the development of
PTS.11–15 Evolution of thrombosis or recurrent throm-
bosis plays an important role on the outcome and
increases the likelihood of PTS development.11
The application of compression aims to reduce the
swelling, accelerate the venous return and improve the
muscle pump function.16 Removable elastic bandages,
inelastic adherent bandages, graduated compression
elastic stockings and intermittent compression pneu-
matic devices can be used to achieve this.17–20
The aim of this systematic review was to assess
whether there is enough evidence to suggest that
compression with or without early ambulation after
proximal DVT reduces the risk of PTS.Eur J Vasc Endovasc Surg 32, 217–221 (2006)
doi:10.1016/j.ejvs.2005.11.036, available online at http://www.sciencedirect.com onved.
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Electronic and hand searching of the relevant litera-
ture was undertaken. MEDLINE from 1966 and
EMBASE from 1980, onwards, Cochrane Library, and
Ovid were searched using the following terms: DVT,
elastic compression, compression, and PTS. In
addition, the following journals were hand-searched:
Phlebology (1990–2004), Journal of Thrombosis and
Haemostasis (2003–2004), and the abstract books of the
Annual Meetings of the European Venous Forum
(2000–2005) and American Venous Forum (1989–2005).
The references of the pertinent papers were searched
as well.
Valid studies to be included in the analysis were
those that had a randomised controlled design in the
evaluation of any kind of compression treatment in
patients with a proven proximal lower limb DVT.
Proximal DVT is defined as that in which thrombus
extends at least up to the popliteal vein.21 One author
(A.D.G.) identified and assessed titles and abstracts for
relevance and the two other authors (N.L., JAM)
independently verified it. The primary outcome was
development of PTS, while other features were
assessed as secondary outcomes such as pulmonary
embolism, DVT recurrence, symptomatic relief and
well-being at the early period after the index event.
Two of the authors (A.D.G., N.L.) extracted the data
independently. Four studies22–25 were identified that
met the inclusion criteria and thus were considered in
the analysis.
The chi square test (c2, p-value), the odds ratio (OR),
relative risk (RR), and relative risk reduction (RRR)
with their 95%CI for the development of PTS were
calculated for each study as well as after pooling all
four studies.Results
In the study by Brandjes et al.,22 194 patients with a
first episode of venographically proven DVT were
assigned either to custom-made elastic size-to-fit
graded elastic stockings (40 mmHg at the ankle,
36 mmHg at the lower calf, and 21 mmHg at the
upper calf) or no stockings. All patients were treated
with heparin for 5 days in the hospital and then
discharged with coumadin treatment on an outpatient
basis for 3 months. Elastic stockings were applied 2–3
weeks after the onset of DVT and patients were
advised to wear them during the day only for at
least 2 years. Thereafter, it was their choice whether to
continue wearing stockings or not. Follow-up was
scheduled on a 3-monthly basis during the first 2 yearsEur J Vasc Endovasc Surg Vol 32, August 2006and 6-monthly thereafter for at least 5 years. The two
groups were well matched in terms of clinical
characteristics, their mean age was 60 years (SD 17)
and 86 (44%) were women.
Primary outcome. During the follow-up PTS
developed in 19 (20%) of 96 patients treated with
elastic compression and in 46 (47%) of 98 in the control
group. The findings favour elastic compression and
the risk reduction was 58%.
Secondary outcome. No information was provided in
respect to early symptomatic relief or the development
of leg ulceration during the follow-up. None of the
patients in either group developed pulmonary embo-
lism during the follow-up and no difference was
demonstrated regarding the development of recurrent
DVT (14.6% in the elastic compression group and
13.3% in the control group).
In the study by Ginsberg et al.,23 82 patients with
a first episode of proximal DVT confirmed by
venography or duplex scanning were treated with
anticoagulation. They were randomly assigned to
below-knee graduated elastic stockings (20–
30 mmHg) or a matched placebo stocking with no
haemodynamic effect (1–2 sizes too large). Patients
were encouraged to wear the stockings as much as
possible during walking hours. Patients who were
asymptomatic at the baseline assessment were advised
to replace stockings every 6 months and were on a
6-month follow up. Those who were symptomatic
replaced the stockings every 3 months and were on a
3-month follow-up.
Primary outcome. During the follow-up period PTS
developed in 11 (26%) of 42 patients in the elastic
compression group and in 11 (27.5%) in the placebo
group. The findings do not favour either treatment and
the risk reduction from wearing elastic compression
was only 5%.
Secondary outcome. No information was provided in
respect to symptomatic relief at the early stage, to
pulmonary embolism and recurrent thrombosis. None
of the patients developed leg ulceration in both
groups.
In the study by Prandoni et al.,24 180 patients with a
first episode of proximal DVT proven by duplex
scanning were treated by anticoagulation (unfractio-
nated or low molecular weight heparin for 5 days
followed by at least 3 months of vitamin K antagonist
therapy). Patients with idiopathic thrombosis received
at least 6 months anticoagulation while patients with
permanent risk factors, such as active cancer, were
treated for the entire study period. Before their
discharge from the hospital (average in-hospital stay
7 days, range: 5–10 days) they were randomised to
either wear below the knee graduated compression
Post-thrombotic Syndrome and Compression 219elastic stockings (30–40 mmHg at the ankle) or no
compression at all for 2 years. All patients were
followed for at least 3 years and a maximum of 5 years.
They were followed-up at 3 and 6 months after the
index event and thereafter every 6 months.
Primary outcome. PTS developed in 23 (25.5%) of 90
patients treated with elastic compression and in 44
(49%) of 90 in the control group. The findings favour
elastic compression and the risk reduction was 48%.
Secondary outcome. During the follow-up period 42%
in the compression group and 41% in the control group
developed symptoms or signs suggestive of recurrent
venous thromboembolism. Of these cases compli-
cations were confirmed in 12 (13.3%) in the
compression group and 13 (14.4%) in the control
group. Of these 25 complications seven were ipsilateral
DVT, 11 were contralateral DVT and seven were
pulmonary embolism episodes three of which were
fatal.
In the study by Partsch et al.,25 53 symptomatic
patients with proximal DVT proven on duplex
scanning treated with deltaparin (200 IU/kg body
weight daily) followed by pheprocoumon (for at least
6 months) were assigned to treatment either with
compression (firm inelastic bandages—Unna boot: 18,
thigh graduated elastic stockings: 18) and deliberate
immediate ambulation (nZ36) or bed rest without any
compression (nZ17) for 9 days. After the first 9 days
all patients were encouraged to walk with com-
pression class II stockings, calf or thigh length
depending on the swelling of the thigh, which were
renewed every 6 months. The patients were assessed
for daily walking distance, pain relief and swelling,
evolution of thrombosis and pulmonary embolism
during the first 9 days after the index event and then
for 2 years for development of PTS. Independent
observers reassessed 37 patients during the follow-up
(bed-rest group: 11, elastic stocking group: 13, and
bandage group: 13). The follow-up investigations took
place 2 years later (28.9G4.9 months).
Primary outcome. PTS developed in eight (31%) of 26
patients treated with any kind of compression





Brandjes et al., 1997 19/96, (20) 46/98
Ginsberg et al., 2001 (part 2 and 3) 11/42, (26) 11/40
Prandoni et al., 2004 23/90, (25.5) 44/90
Rartsch et al., 2004 8/26, (31) 9/11
Total 61/254, (24) 110/239
PTS, post-thrombotic syndrome; RR, relative risk; RRR, relative risk rebed-rest. The findings favour compression and the risk
reduction was 62%.
Secondary outcome. During the early period after the
index event (0–9 days) follow-up improvement of
well-being and DVT-related quality of life was
significantly faster and more pronounced with com-
pression and ambulation than bed-rest (p!0.05 for
stockings, and p!0.001 for bandages). Swelling was
almost completely removed by compression and
clinical scores improved as compared to bed-rest
(p!0.001). No difference was detected in respect to
pain probably because of the small numbers. Throm-
bus progression as studied with ultrasound, was less
frequent and less pronounced in the compression
group. There was no difference in new pulmonary
embolism on repeated lung scans. In the 2-year follow-
up, the recurrence of DVT was nil in the bed rest group
and three in the compression group (one was in the
contralateral limb). Three new episodes of superficial
phlebitis were detected in the bed rest group (one in
the contralateral limb). No differences among the bed-
rest and compression group were seen in respect to
pain and swelling. Also no difference was detected
between the two groups in respect to thrombus
progression or regression/recanalization.
Tables 1 and 2 show the benefit conferred from
compression in each study and when all studies were
pooled. Compression was associated with a 48% risk
reduction.Discussion
This systematic review of the existing randomised
studies on the value of compression after a proximal
DVT shows that this management is associated with a
decreased incidence of PTS as previously reported.26
However, there are a number of methodological
limitations and heterogeneity in the studies which
should be taken into account. In one study power
calculation was not carried out.25 Compliance was
only assessed in two studies.23,24 There was no
uniformity in definition and assessment of PTS. The
duration of anticoagulation varied between andudies
group
N, (%)
p RR (95%CI) RRR (95%CI)
(47) 0.0001 0.42 (0.27, 0.65) 0.58 (0.35, 0.73)
(27.5) 1.0 0.95 (0.47, 1.94) 0.05 (K0.94, 0.53)
(49) 0.002 0.52 (0.35, 0.78) 0.48 (0.22, 0.65)
(82) 0.01 0.37 (0.27, 0.72) 0.62 (0.28, 0.73)
(46) 0.0001 0.52 (0.40, 0.67) 0.48 (0.33, 0.60)
duction.
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Brandies et al 19/96 46/98 42.29 0.28 [0.15, 0.53]
Ginberg et al 11/42 11/40 9.63 0.94 [0.35, 2.49]
Prandoni et al 23/90 44/90 37.94 0.36 [0.19, 0.67]
Rarsch et al 8/26 9/11 10.14 0.10 [0.02, 0.56]
Total (95% Cl) 254 239 100.00 0.35 [0.24, 0.52]
Total events: 61 (Treatment), 110 (control)
Teat for heterogeneity: Chi2 = 6.39, df = 3 (P = 0.09), I2 = 53.1%
Teat for overall effect: Z = 5.22 (P < 0.00001)













A. D. Giannoukas et al.220possible within studies. The compression regimen
varied between different studies.
The definition of PTS remains unresolved and is
somewhat complex as pain and swelling that appears
in the acute phase of proximal DVT usually subsides
within two to twelve weeks, depending on the lysis,
recanalisation, and collateral flow that develops by the
time.14,15 Not all patients develop PTS after proximal
DVT23 and true PTS is a consequence of venous
hypertension secondary to valvular incompetence,
occasionally to residual venous obstruction, or to
both.27–29
Despite the variability in the treatment groups all
but one study demonstrated that compression signifi-
cantly reduces the incidence of PTS without any
additional severe morbidity or mortality. Additionally,
early ambulation even at the acute phase of DVT
combined with compression offered a more favourable
symptomatic outcome compared to bed rest.30,31 This
adds further to the perceived benefits of the treatment
of DVT with low molecular weight heparins by
offering early symptomatic relief and patient’s well
being. Furthermore, it has been shown that exercise
does not worsen symptoms in patients with PTS and it
may improve the flexibility of the affected leg. This
effect was independent of the use of elastic com-
pression.32–34
Studies on the use of elastic compression have
shown that about 20% of patients are not compliant.35,36
Although in the pertinent literature compression with
or without early ambulation appears to be safe, offers
better and faster early outcome, and is associated with
decreased risk of PTS development, the diversity and
subjectivity encountered in the methodology of theEur J Vasc Endovasc Surg Vol 32, August 2006existing studies do not allow a definite conclusion.
A large randomised controlled trial without diversity
in the definition and subjectivity in the assessment is
needed.
Additionally, further research is needed on issues
that remain unresolved such as the optimal timing to
start elastic compression after the episode of DVT, the
minimum required duration of wearing elastic stock-
ings in order to have the beneficial effects and the
optimal pressure needed for such purpose.References
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